Lilei Zhao
-
- Drug-Induced Hepatotoxicity and Protection 3
-
- Liver Disease Diagnosis and Treatment 5
- Autophagy in Disease and Therapy 2
- Adipokines, Inflammation, and Metabolic Diseases 1
-
- Diet, Metabolism, and Disease 2
-
- Andrographolide Research and Applications 1
-
- Genomics, phytochemicals, and oxidative stress 9
-
- NF-κB Signaling Pathways 2
Lilei Zhao
12 papers receiving 335 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 40
- Epidemiology 158
- Endocrinology, Diabetes and Metabolism 64
- Biochemistry 27
- Complementary and alternative medicine 25
Countries citing papers authored by Lilei Zhao
This map shows the geographic impact of Lilei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilei Zhao more than expected).
Fields of papers citing papers by Lilei Zhao
This network shows the impact of papers produced by Lilei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilei Zhao. The network helps show where Lilei Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lilei Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 27 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 75 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 29 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 102 | |
| 10 | 2020 | 33 | |
| 11 | 2018 | 23 | |
| 12 | 2017 | 27 |
About Lilei Zhao
Lilei Zhao is a scholar working on Pharmacology, Epidemiology and Microbiology, having authored 12 papers that have together received 335 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (9 papers), Liver Disease Diagnosis and Treatment (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Autophagy in Disease and Therapy (2 papers), Diet, Metabolism, and Disease (2 papers), NF-κB Signaling Pathways (2 papers), Andrographolide Research and Applications (1 paper) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). The work is most often cited by research in Pharmacology (40 citations), Epidemiology (158 citations) and Endocrinology, Diabetes and Metabolism (64 citations). Lilei Zhao has collaborated with scholars based in China. Frequent co-authors include Jiaqi Cheng, Haihua Feng, Bingyu Shen, Meiyu Jin, Guowen Liu, Haiyan Qin, Qi Wang, Yeling Wang, Zheng Li and Xuming Deng. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.